P3 Health Partners (NASDAQ:PIII – Get Free Report) is one of 34 public companies in the “Health services” industry, but how does it contrast to its rivals? We will compare P3 Health Partners to related businesses based on the strength of its valuation, dividends, risk, analyst recommendations, institutional ownership, earnings and profitability.
Valuation & Earnings
This table compares P3 Health Partners and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|P3 Health Partners||$1.05 billion||-$270.13 million||0.00|
|P3 Health Partners Competitors||$1.51 billion||-$94.28 million||17.34|
P3 Health Partners’ rivals have higher revenue and earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
Institutional & Insider Ownership
23.6% of P3 Health Partners shares are owned by institutional investors. Comparatively, 44.9% of shares of all “Health services” companies are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by insiders. Comparatively, 22.7% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This table compares P3 Health Partners and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|P3 Health Partners||-10.92%||-2,471.27%||33.63%|
|P3 Health Partners Competitors||-136.76%||-192.17%||-18.55%|
This is a summary of recent ratings and target prices for P3 Health Partners and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|P3 Health Partners||0||1||1||0||2.50|
|P3 Health Partners Competitors||10||164||317||0||2.63|
P3 Health Partners currently has a consensus price target of $5.00, suggesting a potential upside of 135.85%. As a group, “Health services” companies have a potential upside of 107.60%. Given P3 Health Partners’ higher possible upside, analysts plainly believe P3 Health Partners is more favorable than its rivals.
P3 Health Partners rivals beat P3 Health Partners on 9 of the 12 factors compared.
P3 Health Partners Company Profile
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.